We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.31B
AUM Growth
-$51.4M
Cap. Flow
-$54.7M
Cap. Flow %
-4.18%
Top 10 Hldgs %
12.11%
Holding
1,682
New
422
Increased
338
Reduced
347
Closed
506

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$18.2M
2
TER icon
Teradyne
TER
+$15.9M
3
BE icon
Bloom Energy
BE
+$15.3M
4
CYBR
CyberArk
CYBR
+$15.2M
5
EXAS
Exact Sciences
EXAS
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 14.62%
3 Consumer Discretionary 10.89%
4 Industrials 8.81%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLYVK icon
651
Liberty Live Group Series C
LLYVK
$9.07B
$346K 0.03%
3,679
-3,181
-46% -$286K
C icon
652
Citigroup
C
$222B
$344K 0.03%
3,033
-2,535
-46% -$289K
TDOC icon
653
Teladoc Health
TDOC
$1.22B
$344K 0.03%
63,085
+2,485
+4% +$13.9K
ALIT icon
654
Alight
ALIT
$447M
$342K 0.03%
29,367
+17,500
+147% +$417K
SBRA icon
655
Sabra Healthcare REIT
SBRA
$5.34B
$342K 0.03%
+17,780
New +$350K
PR
656
Permian Resources
PR
$17.8B
$342K 0.03%
16,026
-1,299
-7% -$22.4K
FBRT
657
Franklin BSP Realty Trust
FBRT
$630M
$341K 0.03%
40,135
INGM
658
Ingram Micro Holding
INGM
$6.51B
$340K 0.03%
+14,600
New +$317K
HTZ icon
659
Hertz
HTZ
$499M
$338K 0.03%
73,419
+15,794
+27% +$76.4K
HRMY icon
660
Harmony Biosciences
HRMY
$2.04B
$338K 0.03%
12,060
+3,900
+48% +$128K
AER icon
661
AerCap
AER
$23.7B
$338K 0.03%
2,462
+265
+12% +$37.9K
IDXX icon
662
Idexx Laboratories
IDXX
$44.1B
$334K 0.03%
+595
New +$382K
META icon
663
PUT
Meta Platforms (Facebook)
META
$1.42T
$334K 0.03%
+39
New +$25K
GPOR icon
664
Gulfport Energy Corp
GPOR
$2.9B
$333K 0.03%
1,572
+52
+3% +$10.3K
WAL icon
665
Western Alliance Bancorporation
WAL
$8.79B
$332K 0.03%
4,693
+2,230
+91% +$186K
IRS
666
IRSA Inversiones y Representaciones
IRS
$1.29B
$332K 0.03%
20,500
+6,500
+46% +$103K
XPER icon
667
Xperi
XPER
$372M
$331K 0.03%
59,078
-20,500
-26% -$119K
SGRY icon
668
Surgery Partners
SGRY
$2.01B
$331K 0.03%
27,743
-35,000
-56% -$502K
MCO icon
669
Moody's
MCO
$82.8B
$331K 0.03%
758
+70
+10% +$33.1K
ACMR icon
670
ACM Research
ACMR
$5.42B
$330K 0.03%
8,396
-487
-5% -$25.9K
DRS icon
671
Leonardo DRS
DRS
$12.3B
$330K 0.03%
7,413
-970
-12% -$40.9K
BSX icon
672
Boston Scientific
BSX
$69.5B
$330K 0.03%
5,253
-1,527
-23% -$122K
THC icon
673
Tenet Healthcare
THC
$20.5B
$329K 0.03%
1,743
-2,011
-54% -$424K
CE icon
674
Celanese
CE
$4.9B
$329K 0.03%
5,000
-167
-3% -$8.72K
BELFB
675
Bel Fuse Inc Class B
BELFB
$3.87B
$329K 0.03%
+1,661
New +$347K

Similar funds

Prelude Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Prelude Capital Management held 1,682 positions worth $1.31B, down 3.8% from $1.36B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $54.7M in Q1 2026, closing 506 positions and reducing 347 holdings. Its most notable exit was CyberArk, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Appian worth $9.41M.

  • Prelude Capital Management's largest Q1 2026 buy was Appian: 390,321 shares worth $9.41M.
  • Prelude Capital Management added most to Penumbra in Q1 2026, an estimated $15.3M increase.
  • Prelude Capital Management's biggest Q1 2026 reduction was SPDR Gold Trust, cutting an estimated $18.2M.
  • Prelude Capital Management fully exited CyberArk in Q1 2026, selling an estimated $15.2M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.31B portfolio in Q1 2026.
  • Prelude Capital Management opened 422 new positions and closed 506 in Q1 2026.
  • Prelude Capital Management's portfolio value fell 3.8% quarter-over-quarter to $1.31B.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.